Inventor
WIEGAND STANLEY J
US17 patents
Patents
17 patentsUS7306799B2Dec 11, 2007
Use of VEGF inhibitors for treatment of eye disorders
REGENERON PHARMA140 citations99
US7303747B2Dec 4, 2007
Use of VEGF inhibitors for treatment of eye disorders
REGENERON PHARMA112 citations99
US7531173B2May 12, 2009
Ophthalmic composition of a VEGF antagonist
REGENERON PHARMA109 citations98
US7521049B2Apr 21, 2009
Use of VEGF inhibitors for treatment of eye disorders
REGENERON PHARMA74 citations98
US9265827B2Feb 23, 2016
Anti-PDGFR-beta antibodies and uses thereof
REGENERON PHARMA87 citations97
US7303746B2Dec 4, 2007
Methods of treating eye disorders with modified chimeric polypeptides
REGENERON PHARMA117 citations97
US7303748B2Dec 4, 2007
Method of treating eye injury with local administration of a VEGF inhibitor
REGENERON PHARMA49 citations95
US7378095B2May 27, 2008
Methods of treating type I diabetes by blocking VEGF-mediated activity
REGENERON PHARMA24 citations92
US7309483B2Dec 18, 2007
Method of treatment using Tie2 ligand2
REGENERON PHARMA32 citations92
US7052691B2May 30, 2006
Methods of treating diabetes by blocking VEGF-mediated activity
REGENERON PHARMA32 citations92
US9650444B2May 16, 2017
Anti-PDGFR-beta antibodies and uses thereof
REGENERON PHARMA12 citations83
US6472178B1Oct 29, 2002
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
REGENERON PHARMA13 citations80
US6410510B1Jun 25, 2002
Administration modified ciliary neurotrophic factors
REGENERON PHARMA7 citations73
US6680291B1Jan 20, 2004
Modified ciliary neurotrophic factor, method of making and methods of use thereof
REGENERON PHARMA6 citations68
US11071780B2Jul 27, 2021
Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab
REGENERON PHARMA0 citations58
US10023642B2Jul 17, 2018
Anti-PDGFR-beta antibodies and uses thereof
REGENERON PHARMA0 citations51
US7119066B2Oct 10, 2006
Modified ciliary neurotrophic factor (CNTF)
REGENERON PHARMA0 citations50